BAY 87-2243 25 mg | 99.65%
TargetMol
BAY 87-2243 is a potent and selective inhibitor of hypoxia-inducible factor-1 (HIF-1).
More Information Supplier PageBAY 87-2243
Search Results
BAY 87-2243 2 mg | 99.65%
TargetMol
BAY 87-2243 is a potent and selective inhibitor of hypoxia-inducible factor-1 (HIF-1).
More Information Supplier PageBAY 87-2243
Loxiglumide 5 mg | Purity Not Available
TargetMol
Loxiglumide
BIIB021 25 mg | 98.38%
TargetMol
BIIB021 is an orally-available, fully synthetic inhibitor of HSP90(Ki=1.7 nM, EC50=38 nM).
More Information Supplier PageBIIB021
Itanapraced 25 mg | 98.00%
TargetMol
Itanapraced (CHF5074), a γ-secretase modulator, reduces Aβ42/40 secretion (IC50: 3.6/18.4 μM).
More Information Supplier PageItanapraced
Itanapraced 1 mg | 98.00%
TargetMol
Itanapraced (CHF5074), a γ-secretase modulator, reduces Aβ42/40 secretion (IC50: 3.6/18.4 μM).
More Information Supplier PageItanapraced
NVP-TAE 684 100 mg | Purity Not Available
TargetMol
NVP-TAE 684 is a excellently effective and specific ALK inhibitor(IC50=3 nM).
More Information Supplier PageNVP-TAE 684
NVP-TAE 684 25 mg | Purity Not Available
TargetMol
NVP-TAE 684 is a excellently effective and specific ALK inhibitor(IC50=3 nM).
More Information Supplier PageNVP-TAE 684
NVP-TAE 684 2 mg | Purity Not Available
TargetMol
NVP-TAE 684 is a excellently effective and specific ALK inhibitor(IC50=3 nM).
More Information Supplier PageNVP-TAE 684
Loxiglumide 25 mg | Purity Not Available
TargetMol
Loxiglumide